HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
2000
7801	7801 Almeida A, Tavares I, Lima D Reciprocal connections between the medullary dorsal reticular nucleus and the spinal dorsal horn in the rat EUROPEAN JOURNAL OF PAIN. 2000; 4 (4): 373-387	0	13	5	91
7802	7802 Kapaki E, Paraskevas GP, Michalopoulou M, Kilidireas K Increased cerebrospinal fluid tau protein in multiple sclerosis EUROPEAN NEUROLOGY. 2000; 43 (4): 228-232	13	41	5	14
7803	7803 Savaskan E, Muller-Spahn F, Olivieri G, Bruttel S, Otten U, et al. Alterations in trk A, trk B and trk C receptor immunoreactivities in parietal cortex and cerebellum in Alzheimer's disease EUROPEAN NEUROLOGY. 2000; 44 (3): 172-180	9	25	3	34
7804	7804 Lansbury PT The role of alpha-synuclein in Parkinson's disease: A biophysical analogy to A beta and Alzheimer's disease FATAL ATTRACTIONS: PROTEIN AGGREGATES IN NEURODEGENERATIVE DISORDERS. 2000; : 1-9	0	0	10	37
7805	7805 Iwatsubo T, Baba M, Lee VMY, Trojanowski JQ Purification of Lewy bodies and identification of alpha-synuclein as a major component of Lewy bodies FATAL ATTRACTIONS: PROTEIN AGGREGATES IN NEURODEGENERATIVE DISORDERS. 2000; : 11-18	2	2	15	19
7806	7806 Wilhelmsen KC, Clark LN, Geshwind DH, Miller BL Mutational analysis of tau in chromosome 17-linked dementia FATAL ATTRACTIONS: PROTEIN AGGREGATES IN NEURODEGENERATIVE DISORDERS. 2000; : 19-28	0	0	8	34
7807	7807 Hutton M, Lovestone S, Heutink P, Pickering-Brown S, Yen SH Missense and splice site mutations in Tau associated with FTDP-17 multiple pathogenic mechanisms FATAL ATTRACTIONS: PROTEIN AGGREGATES IN NEURODEGENERATIVE DISORDERS. 2000; : 29-51	0	0	34	51
7808	7808 Poorkaj P, D'Souza I, Bird TD, Schellenberg GD Tau mutations: Genetics and pathogenetic mechanisms FATAL ATTRACTIONS: PROTEIN AGGREGATES IN NEURODEGENERATIVE DISORDERS. 2000; : 53-64	1	1	29	61
7809	7809 Goedert M, Spillantini MG Tauopathies and alpha-synucleinopathies FATAL ATTRACTIONS: PROTEIN AGGREGATES IN NEURODEGENERATIVE DISORDERS. 2000; : 65-86	2	2	66	85
7810	7810 Lee VMY, Trojanowski JQ Distinct tau gene mutations induce specific dysfunctions/toxic properties in tau proteins associated with specific FTDP-17 phenotypes FATAL ATTRACTIONS: PROTEIN AGGREGATES IN NEURODEGENERATIVE DISORDERS. 2000; : 87-104	1	1	108	177
#	Date / Author / Journal	LCS	GCS	LCR	CR
7811	7811 Buee L, Mailliot C, Bussiere T, Sergeant N, Buee-Scherrer V, et al. Neurodegenerative disorders with tauopathies: Mad tau diseases? FATAL ATTRACTIONS: PROTEIN AGGREGATES IN NEURODEGENERATIVE DISORDERS. 2000; : 105-125	2	2	66	105
7812	7812 Mandelkow EM, Biernat J, Ebneth A, Stamer K, Godemann R, et al. Tau protein: Role in intracellular traffic and development of cell polarity FATAL ATTRACTIONS: PROTEIN AGGREGATES IN NEURODEGENERATIVE DISORDERS. 2000; : 127-138	1	1	19	45
7813	7813 Chevion M, Berenshtein E, Stadtman ER Human studies related to protein oxidation: Protein carbonyl content as a marker of damage FREE RADICAL RESEARCH. 2000; 33: S99-S108	3	82	1	71
7814	7814 Gopaul NK, Halliwell B, Anggard EE Measurement of plasma F-2-isoprostanes as an index of lipid peroxidation does not appear to be confounded by diet FREE RADICAL RESEARCH. 2000; 33 (2): 115-127	7	38	1	37
7815	7815 Iwatsubo T Protein aggregation in neurodegenerative disorders: Alzheimer's disease and Parkinson's disease FRONTIERS OF THE MECHANISMS OF MEMORY AND DEMENTIA. 2000; (1200): 137-138	0	0	4	8
7816	7816 Masters CL, Beyreuther K Genetic basis of resistance to Alzheimer's disease and related neurodegenerative diseases GENES AND RESISTANCE TO DISEASE. 2000; : 121-131	0	0	10	51
7817	7817 Shamovsky IL, Ross GM, Riopelle RJ, Weaver DF Molecular modeling of the interaction of neurotrophins with the p75(NTR) common neurotrophin receptor HIGH PERFORMANCE COMPUTING SYSTEMS AND APPLICATIONS. 2000; 541: 99-113	0	0	6	60
7818	7818 Heutink P Untangling tau-related dementia HUMAN MOLECULAR GENETICS. 2000; 9 (6): 979-986	58	69	59	76
7819	7819 Bresjanac M Role of inflammatory-immune-neurotrophic interactions in neurotransplantation outcome IMMUNOPHILINS IN THE BRAIN. 2000; : 199-207	0	0	7	46
7820	7820 Althaus HH, Richter-Landsberg C Glial cells as targets and producers of neurotrophins INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL. 197. 2000; 197: 203-277	1	45	30	529
#	Date / Author / Journal	LCS	GCS	LCR	CR
7821	7821 Farlow DN, Vansant G, Cameron AA, Chang J, Khoh-Reiter S, et al. Gene expression monitoring for gene discovery in models of peripheral and central nervous system differentiation, regeneration, and trauma JOURNAL OF CELLULAR BIOCHEMISTRY. 2000; 80 (2): 171-180	0	5	3	26
7822	7822 Mizuno Y, Hattori N, Asakawa S, Shimura H, Mori H, et al. Progress in familial Parkinson's disease JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION. 2000; 28 (3): 143-157	0	0	37	88
7823	7823 Jellinger KA Cell death mechanisms in Parkinson's disease JOURNAL OF NEURAL TRANSMISSION. 2000; 107 (1): 1-29	34	145	44	237
7824	7824 Kruger R, Muller T, Riess O Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative disorders JOURNAL OF NEURAL TRANSMISSION. 2000; 107 (1): 31-40	25	39	20	56
7825	7825 Holzer M, Bruckner MK, Beck M, Bigl V, Arendt T Modulation of APP processing and secretion by okadaic acid in primary guinea pig neurons JOURNAL OF NEURAL TRANSMISSION. 2000; 107 (4): 451-461	5	6	7	25
7826	7826 Sjogren M, Minthon L, Davidsson P, Granerus AK, Clarberg A, et al. CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging JOURNAL OF NEURAL TRANSMISSION. 2000; 107 (5): 563-579	72	112	18	61
7827	7827 Wellington CL, Leavitt BR, Hayden MR Huntington disease: new insights on the role of huntingtin cleavage JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2000; (58): 1-17	0	16	13	30
7828	7828 Shimizu N, Asakawa S, Minoshima S, Kitada T, Hattori N, et al. PARKIN as a pathogenic gene for autosomal recessive juvenile parkinsonism JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2000; (58): 19-30	1	7	9	31
7829	7829 Gasser T Autosomal-dominantly inherited forms of Parkinson's disease JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2000; (58): 31-40	4	6	12	49
7830	7830 McLean PJ, Ribich S, Hyman BT Subcellular localization of alpha-synuclein in primary neuronal cultures: effect of missense mutations JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2000; (58): 53-63	22	22	7	16
#	Date / Author / Journal	LCS	GCS	LCR	CR
7831	7831 Offen D, Elkon H, Melamed E Apoptosis as a general cell death pathway in neurodegenerative diseases JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2000; (58): 153-166	1	17	12	87
7832	7832 Tsuji S Dentatorubral-pallidoluysian atrophy (DRPLA) JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2000; (58): 167-180	2	3	14	102
7833	7833 Schmidt H, Fazekas F, Kostner GM, Schmidt R Genetic aspects of microangiopathy-related cerebral damage JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2000; (59): 15-21	0	8	9	28
7834	7834 Jellinger KA, Stadelmann C Mechanisms of cell death in neurodegenerative disorders JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2000; (59): 95-114	0	51	35	123
7835	7835 Albers DS, Beal MF Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2000; (59): 133-154	0	119	18	185
7836	7836 Masliah E, Rockenstein E Genetically altered transgenic models of Alzheimer's disease JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2000; (59): 175-183	0	24	8	42
7837	7837 Jellinger KA Morphological substrates of mental dysfunction in Lewy body disease: an update JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2000; (59): 185-212	0	34	37	151
7838	7838 Iqbal K, Alonso AD, Gondal JA, Gong CX, Haque N, et al. Mechanism of neurofibrillary degeneration and pharmacologic therapeutic approach JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2000; (59): 213-222	0	11	20	47
7839	7839 Wronski R, Kronawetter S, Hutter-Paier B, Crailsheim K, Windisch M A brain derived peptide preparation reduces the translation dependent loss of a cytoskeletal protein in primary cultured chicken neurons JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2000; (59): 263-272	0	1	10	50
7840	7840 Morton AJ, Lagan MA, Skepper JN, Dunnett SB Progressive formation of inclusions in the striatum and hippocampus of mice transgenic for the human Huntington's disease mutation JOURNAL OF NEUROCYTOLOGY. 2000; 29 (9): 679-702	8	52	23	50
#	Date / Author / Journal	LCS	GCS	LCR	CR
7841	7841 Chapman RS, Hesketh LJ Behavioral phenotype of individuals with Down syndrome MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS. 2000; 6 (2): 84-95	1	108	2	153
7842	7842 Kagoura M, Toyoda M, Matsui C, Morohashi M Merkel cell carcinoma: an immunohistochemical and ultrastructural study MERKEL CELLS, MERKEL CELL CARCINOMA AND NEUROBIOLOGY OF THE SKIN. 2000; 1187: 169-172	0	0	1	7
7843	7843 Lazarov NE The mesencephalic trigeminal nucleus in the cat MESENCEPHALIC TRIGEMINAL NUCLEUS IN THE CAT. 2000; 153: 1-+	1	14	11	431
7844	7844 Bornemann KD, Staufenbiel M Transgenic mouse models of Alzheimer's disease MOLECULAR AND CELLULAR GERONTOLOGY. 2000; 908: 260-266	13	41	6	25
7845	7845 Gomez-Tortosa E, Irizarry MC, Gomez-Isla T, Hyman BT Clinical and neuropathological correlates of dementia with Lewy bodies MOLECULAR BASIS OF DEMENTIA. 2000; 920: 9-15	14	20	7	19
7846	7846 Spillantini MG, Goedert M The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy MOLECULAR BASIS OF DEMENTIA. 2000; 920: 16-27	86	103	47	82
7847	7847 Polymeropoulos MH Genetics of Parkinson's disease MOLECULAR BASIS OF DEMENTIA. 2000; 920: 28-32	23	38	9	27
7848	7848 Kahle PJ, Neumann M, Ozmen L, Haass C Physiology and pathophysiology of alpha-synuclein - Cell culture and transgenic animal models based on a Parkinson's disease-associated protein MOLECULAR BASIS OF DEMENTIA. 2000; 920: 33-41	33	37	38	62
7849	7849 Conway KA, Lee SJ, Rochet JC, Ding TT, Harper JD, et al. Accelerated oligomerization by Parkinson's disease linked alpha- synuclein mutants MOLECULAR BASIS OF DEMENTIA. 2000; 920: 42-45	52	64	10	20
7850	7850 Neary D, Snowden JS, Mann DMA Classification and description of frontotemporal dementias MOLECULAR BASIS OF DEMENTIA. 2000; 920: 46-51	26	42	2	12
#	Date / Author / Journal	LCS	GCS	LCR	CR
7851	7851 Ghetti B, Murrell JR, Zolo P, Spillantini MG, Goedert M Progress in hereditary tauopathies: A mutation in the Tau gene (G389R) causes a Pick disease-like syndrome MOLECULAR BASIS OF DEMENTIA. 2000; 920: 52-62	14	14	36	47
7852	7852 Hutton M Molecular genetics of chromosome 17 tauopathies MOLECULAR BASIS OF DEMENTIA. 2000; 920: 63-73	29	34	30	37
7853	7853 Goedert M, Ghetti B, Spillantini MG Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) - Their relevance for understanding the neurogenerative process MOLECULAR BASIS OF DEMENTIA. 2000; 920: 74-83	17	26	50	66
7854	7854 Finckh U, Muller-Thomsen T, Mann U, Eggers C, Marksteiner J, et al. High frequency of mutations in four different disease genes in early- onset dementia MOLECULAR BASIS OF DEMENTIA. 2000; 920: 100-106	1	6	3	29
7855	7855 Mailliot C, Bussiere T, Hamdane M, Sergeant N, Caillet ML, et al. Pathological tau phenotypes - The weight of mutations, polymorphisms, and differential neuronal vulnerabilities MOLECULAR BASIS OF DEMENTIA. 2000; 920: 107-114	4	14	14	18
7856	7856 Rosso SM, Kamphorst W, Ravid R, van Swieten JC Coexistent tau and amyloid pathology in hereditary frontotemporal dementia with tau mutations MOLECULAR BASIS OF DEMENTIA. 2000; 920: 115-119	13	13	16	20
7857	7857 Gotz J, Barmettler R, Ferrari A, Goedert M, Probst A, et al. In vivo analysis of wild-type and FTDP-17 tau transgenic mice MOLECULAR BASIS OF DEMENTIA. 2000; 920: 126-133	9	10	11	24
7858	7858 Price DL, Wong PC, Markowska AL, Lee MK, Thinakaren G, et al. The value of transgenic models for the study of neurodegenerative diseases MOLECULAR BASIS OF DEMENTIA. 2000; 920: 179-191	14	33	19	101
7859	7859 Barbas H Complementary roles of prefrontal cortical regions in cognition, memory, and emotion in primates NEOCORTICAL EPILEPSIES. 2000; 84: 87-110	3	17	36	216
7860	7860 Taylor DC Cerebral lesions, psychoses, and epilepsy: Disease versus illness NEOCORTICAL EPILEPSIES. 2000; 84: 463-477	0	0	1	54
#	Date / Author / Journal	LCS	GCS	LCR	CR
7861	7861 Beattie MS, Li Q, Bresnahan JC Cell death and plasticity after experimental spinal cord injury NEURAL PLASTICITY AND REGENERATION. 2000; 128: 9-21	1	32	10	72
7862	7862 Bethea JR Spinal cord injury-induced inflammation: a dual-edged sword NEURAL PLASTICITY AND REGENERATION. 2000; 128: 33-42	3	48	2	95
7863	7863 Rao MS, Mayer-Proschel M Precursor cells for transplantation NEURAL PLASTICITY AND REGENERATION. 2000; 128: 273-292	3	22	12	167
7864	7864 Lee VMY, Hartley RS, Trojanowski JQ Neurobiology of human neurons (NT2N) grafted into mouse spinal cord: implications for improving therapy of spinal cord injury NEURAL PLASTICITY AND REGENERATION. 2000; 128: 299-307	19	19	24	86
7865	7865 Sinden JD, Stroemer P, Grigoryan G, Patel S, French SJ, et al. Functional repair with neural stem cells NEURAL TRANSPLANTATION IN NEURODEGENERATIVE DISEASE: CURRENT STATUS AND NEW DIRECTIONS. 2000; 231: 270-283	13	17	5	24
7866	7866 Kvetnoy IM, Hernandez-Yago J, Hernandez JM, Kvetnaia TV, Reiter RJ, et al. Diffuse neuroendocrine system and mitochondrial diseases: molecular and cellular bases of pathogenesis, new approaches to diagnosis and therapy. NEUROENDOCRINOLOGY LETTERS. 2000; 21 (2): 83-99	0	3	14	146
7867	7867 Kvetnoy IM, Hernandez-Yago J, Kvetnaia TV, Khavinson VK, Malinin VV, et al. Tau-protein expression in human blood lymphocytes: a promising marker and suitable sample for life-time diagnosis of Alzheimer's disease NEUROENDOCRINOLOGY LETTERS. 2000; 21 (4): 313-318	0	3	11	29
7868	7868 Chen JL, Li Y, Chopp M Intracerebral transplantation of bone marrow with BDNF after MCAo in rat NEUROPHARMACOLOGY. 2000; 39 (5): 711-716	24	86	1	36
7869	7869 Kimura T, Shono M, Yokota S, Igata-Yi R, Takamatsu J, et al. Apolipoprotein E epsilon 3 allele is not a risk factor of schizophrenia: A study of 314 Japanese patients NEUROPSYCHOBIOLOGY. 2000; 42 (2): 66-68	6	6	4	20
7870	7870 Puschban Z, Scherfler C, Granata R, Laboyrie P, Quinn NP, et al. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D-1 and D-2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts NEUROSCIENCE. 2000; 95 (2): 377-388	7	19	4	75
#	Date / Author / Journal	LCS	GCS	LCR	CR
7871	7871 Yee BK Cytotoxic lesion of the medial prefrontal cortex abolishes the partial reinforcement extinction effect, attenuates prepulse inhibition of the acoustic startle reflex and induces transient hyperlocomotion, while sparing spontaneous object recognition memory in the rat NEUROSCIENCE. 2000; 95 (3): 675-689	1	39	1	86
7872	7872 Morrison B, Eberwine JH, Meaney DF, McIntosh TK Traumatic injury induces differential expression of cell death genes in organotypic brain slice cultures determined by complementary DNA array hybridization NEUROSCIENCE. 2000; 96 (1): 131-139	13	40	11	74
7873	7873 Kanda S, Bishop JF, Eglitis MA, Yang Y, Mouradian MM Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation NEUROSCIENCE. 2000; 97 (2): 279-284	118	123	18	28
7874	7874 Coughlan CM, McManus CM, Sharron M, Gao ZY, Murphy D, et al. Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons NEUROSCIENCE. 2000; 97 (3): 591-600	9	120	5	46
7875	7875 Ferrer I, Puig B, Blanco R, Marti E Prion protein deposition and abnormal synaptic protein expression in the cerebellum in Creutzfeldt-Jakob disease NEUROSCIENCE. 2000; 97 (4): 715-726	2	27	1	68
7876	7876 Sadahiro S, Yoshikawa H, Yagi N, Yamamoto Y, Yanagihara T, et al. Morphometric analysis of the myelin-associated oligodendrocytic basic protein-deficient mouse reveals a possible role for myelin-associated oligodendrocytic basic protein in regulating axonal diameter NEUROSCIENCE. 2000; 98 (2): 361-367	0	10	6	33
7877	7877 Scherfler C, Puschban Z, Ghorayeb I, Goebel GP, Tison F, et al. Complex motor disturbances in a sequential double lesion rat model of striatonigral degeneration (multiple system atrophy) NEUROSCIENCE. 2000; 99 (1): 43-54	13	25	7	74
7878	7878 Shepherd CE, Bowes S, Parkinson D, Cambray-Deakin M, Pearson RCA Expression of amyloid precursor protein in human astrocytes in vitro: Isoform-specific increases following heat shock NEUROSCIENCE. 2000; 99 (2): 317-325	1	13	7	50
7879	7879 Newman MP, Feron F, Mackay-Sim A Growth factor regulation of neurogenesis in adult olfactory epithelium. NEUROSCIENCE. 2000; 99 (2): 343-350	5	49	5	48
7880	7880 Blaha GR, Raghupathi R, Saatman KE, Mcintosh TK Brain-derived neurotrophic factor administration after traumatic brain injury in the rat does not protect against behavioral or histological deficits NEUROSCIENCE. 2000; 99 (3): 483-493	12	33	7	91
#	Date / Author / Journal	LCS	GCS	LCR	CR
7881	7881 Kawamoto Y, Nakamura S, Matsuo A, Akiguchi I, Shibasaki H Immunohistochemical localization of glial cell line-derived neurotrophic factor in the human central nervous system NEUROSCIENCE. 2000; 100 (4): 701-712	3	18	14	73
7882	7882 Harkany T, Dijkstra IM, Oosterink BJ, Horvath KM, Abraham I, et al. Increased amyloid precursor protein expression and serotonergic sprouting following excitotoxic lesion of the rat magnocellular nucleus basalis: Neuroprotection by Ca2+ antagonist nimodipine NEUROSCIENCE. 2000; 101 (1): 101-114	5	29	6	52
7883	7883 Burke WJ, Li SW, Schmitt CA, Zahm DS, Chung HD, et al. Catecholamine-derived aldehyde neurotoxins NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS. 2000; : 167-180	4	7	8	54
7884	7884 Dryhurst G, Shen XM, Li H, Yang ZL, Han JL, et al. Potential roles of accelerated dopamine oxidation, altered glutathione metabolism, 5-S-cysteinyl-dopamine and its oxidative metabolites in the pathogenesis of Parkinson's disease NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS. 2000; : 181-209	0	1	4	164
7885	7885 Feany MB Simple genetic models of human neurologic disease NEW CONCEPTS IN THE IMMUNOPATHOGENESIS OF CNS INFECTIONS. 2000; : 337-360	0	0	7	124
7886	7886 Braak H, Del Tredici K, Bohl J, Bratzke H, Braak E Pathological changes in the parahippocampal region in select non- Alzheimer's dementias PARAHIPPOCAMPAL REGION. 2000; 911: 221-239	11	26	16	58
7887	7887 Van Hoesen GW, Augustinack JC, Dierking J, Redman SJ, Thangavel R The parahippocampal gyrus in Alzheimer's disease - Clinical and preclinical neuroanatomical correlates PARAHIPPOCAMPAL REGION. 2000; 911: 254-274	9	41	10	75
7888	7888 Arnold SE Cellular and molecular neuropathology of the parahippocampal region in schizophrenia PARAHIPPOCAMPAL REGION. 2000; 911: 275-292	19	51	25	111
7889	7889 Benes FM, Berretta S Amygdalo-entorhinal inputs to the hippocampal formation in relation to schizophrenia PARAHIPPOCAMPAL REGION. 2000; 911: 293-304	11	54	5	56
7890	7890 Pow CS, Whitehead JS, Moss MS Immunohistochemistry: Methods and troubleshooting PATHOLOGY OF GENETICALLY ENGINEERED MICE. 2000; : 23-32	0	2	1	15
#	Date / Author / Journal	LCS	GCS	LCR	CR
7891	7891 Lomnitski L, Nyska A, Michaelson DM Transgenic and knockout mice with neuropathological disorders PATHOLOGY OF GENETICALLY ENGINEERED MICE. 2000; : 253-268	0	0	20	99
7892	7892 Adesina AM, Dunn ST, Moore WE, Nalbantoglu J Expression of p27kip1 and p53 in medulloblastoma: Relationship with cell proliferation and survival PATHOLOGY RESEARCH AND PRACTICE. 2000; 196 (4): 243-250	7	11	3	34
7893	7893 Bartold PM, Walsh LJ, Narayanan S Molecular and cell biology of the gingiva PERIODONTOLOGY 2000. 2000; 24: 28-55	1	46	3	242
7894	7894 Lin B, Ginsberg MD The roles of beta-amyloid precursor protein and amyloid beta peptide in ischemic brain injury PHARMACOLOGY OF CEREBRAL ISCHEMIA 2000. 2000; : 37-52	0	0	10	109
7895	7895 Schallert T, Bland ST, Fleming SM Functional recovery after brain injury: role of neurotrophic factors and behavior-driven structural events PHARMACOLOGY OF CEREBRAL ISCHEMIA 2000. 2000; : 329-344	1	5	4	164
7896	7896 Loddick SA Inflammatory and anti-inflammatory cytokines and neuronal cell death PHARMACOLOGY OF CEREBRAL ISCHEMIA 2000. 2000; : 417-424	0	0	1	84
7897	7897 Chopp M, Li Y, Chen J Treatment of neural injury with bone marrow PHARMACOLOGY OF CEREBRAL ISCHEMIA 2000. 2000; : 483-490	0	0	6	70
7898	7898 Chen SG, Zou W, Parchi P, Gambetti P PrPSc typing by N-terminal sequencing and mass spectrometry PRION DISEASES. 2000; : 209-216	2	10	8	24
7899	7899 Safar J, Cohen FE, Prusiner SB Quantitative traits of prion strains are enciphered in the conformation of the prion protein PRION DISEASES. 2000; : 227-235	0	5	4	32
7900	7900 Poljak A, Pamphlett R, Gurney ME, Duncan MW Measurement of o- and m-tyrosine as markers of oxidative damage in motor neuron disease REDOX REPORT. 2000; 5 (2-3): 137-140	0	1	1	14

Date / Author / Journal

LCS

GCS

LCR

2000

7801

7801 Almeida A, Tavares I, Lima D

Reciprocal connections between the medullary dorsal reticular nucleus and the spinal dorsal horn in the rat

EUROPEAN JOURNAL OF PAIN. 2000; 4 (4): 373-387

7802

7802 Kapaki E, Paraskevas GP, Michalopoulou M, Kilidireas K

Increased cerebrospinal fluid tau protein in multiple sclerosis

EUROPEAN NEUROLOGY. 2000; 43 (4): 228-232

7803

7803 Savaskan E, Muller-Spahn F, Olivieri G, Bruttel S, Otten U, et al.

Alterations in trk A, trk B and trk C receptor immunoreactivities in parietal cortex and cerebellum in Alzheimer's disease

EUROPEAN NEUROLOGY. 2000; 44 (3): 172-180

7804

7804 Lansbury PT

The role of alpha-synuclein in Parkinson's disease: A biophysical analogy to A beta and Alzheimer's disease

FATAL ATTRACTIONS: PROTEIN AGGREGATES IN NEURODEGENERATIVE DISORDERS. 2000; : 1-9

7805

7805 Iwatsubo T, Baba M, Lee VMY, Trojanowski JQ

Purification of Lewy bodies and identification of alpha-synuclein as a major component of Lewy bodies

FATAL ATTRACTIONS: PROTEIN AGGREGATES IN NEURODEGENERATIVE DISORDERS. 2000; : 11-18

7806

7806 Wilhelmsen KC, Clark LN, Geshwind DH, Miller BL

Mutational analysis of tau in chromosome 17-linked dementia

FATAL ATTRACTIONS: PROTEIN AGGREGATES IN NEURODEGENERATIVE DISORDERS. 2000; : 19-28

7807

7807 Hutton M, Lovestone S, Heutink P, Pickering-Brown S, Yen SH

Missense and splice site mutations in Tau associated with FTDP-17 multiple pathogenic mechanisms

FATAL ATTRACTIONS: PROTEIN AGGREGATES IN NEURODEGENERATIVE DISORDERS. 2000; : 29-51

7808

7808 Poorkaj P, D'Souza I, Bird TD, Schellenberg GD

Tau mutations: Genetics and pathogenetic mechanisms

FATAL ATTRACTIONS: PROTEIN AGGREGATES IN NEURODEGENERATIVE DISORDERS. 2000; : 53-64

7809

7809 Goedert M, Spillantini MG

Tauopathies and alpha-synucleinopathies

FATAL ATTRACTIONS: PROTEIN AGGREGATES IN NEURODEGENERATIVE DISORDERS. 2000; : 65-86

7810

7810 Lee VMY, Trojanowski JQ

Distinct tau gene mutations induce specific dysfunctions/toxic properties in tau proteins associated with specific FTDP-17 phenotypes

FATAL ATTRACTIONS: PROTEIN AGGREGATES IN NEURODEGENERATIVE DISORDERS. 2000; : 87-104

108

177

Date / Author / Journal

LCS

GCS

LCR

7811

7811 Buee L, Mailliot C, Bussiere T, Sergeant N, Buee-Scherrer V, et al.

Neurodegenerative disorders with tauopathies: Mad tau diseases?

FATAL ATTRACTIONS: PROTEIN AGGREGATES IN NEURODEGENERATIVE DISORDERS. 2000; : 105-125

105

7812

7812 Mandelkow EM, Biernat J, Ebneth A, Stamer K, Godemann R, et al.

Tau protein: Role in intracellular traffic and development of cell polarity

FATAL ATTRACTIONS: PROTEIN AGGREGATES IN NEURODEGENERATIVE DISORDERS. 2000; : 127-138

7813

7813 Chevion M, Berenshtein E, Stadtman ER

Human studies related to protein oxidation: Protein carbonyl content as a marker of damage

FREE RADICAL RESEARCH. 2000; 33: S99-S108

7814

7814 Gopaul NK, Halliwell B, Anggard EE

Measurement of plasma F-2-isoprostanes as an index of lipid peroxidation does not appear to be confounded by diet

FREE RADICAL RESEARCH. 2000; 33 (2): 115-127

7815

7815 Iwatsubo T

Protein aggregation in neurodegenerative disorders: Alzheimer's disease and Parkinson's disease

FRONTIERS OF THE MECHANISMS OF MEMORY AND DEMENTIA. 2000; (1200): 137-138

7816

7816 Masters CL, Beyreuther K

Genetic basis of resistance to Alzheimer's disease and related neurodegenerative diseases

GENES AND RESISTANCE TO DISEASE. 2000; : 121-131

7817

7817 Shamovsky IL, Ross GM, Riopelle RJ, Weaver DF

Molecular modeling of the interaction of neurotrophins with the p75(NTR) common neurotrophin receptor

HIGH PERFORMANCE COMPUTING SYSTEMS AND APPLICATIONS. 2000; 541: 99-113

7818

7818 Heutink P

Untangling tau-related dementia

HUMAN MOLECULAR GENETICS. 2000; 9 (6): 979-986

7819

7819 Bresjanac M

Role of inflammatory-immune-neurotrophic interactions in neurotransplantation outcome

IMMUNOPHILINS IN THE BRAIN. 2000; : 199-207

7820

7820 Althaus HH, Richter-Landsberg C

Glial cells as targets and producers of neurotrophins

INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL. 197. 2000; 197: 203-277

529

Date / Author / Journal

LCS

GCS

LCR

7821

7821 Farlow DN, Vansant G, Cameron AA, Chang J, Khoh-Reiter S, et al.

Gene expression monitoring for gene discovery in models of peripheral and central nervous system differentiation, regeneration, and trauma

JOURNAL OF CELLULAR BIOCHEMISTRY. 2000; 80 (2): 171-180

7822

7822 Mizuno Y, Hattori N, Asakawa S, Shimura H, Mori H, et al.

Progress in familial Parkinson's disease

JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION. 2000; 28 (3): 143-157

7823

7823 Jellinger KA

Cell death mechanisms in Parkinson's disease

JOURNAL OF NEURAL TRANSMISSION. 2000; 107 (1): 1-29

145

237

7824

7824 Kruger R, Muller T, Riess O

Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative disorders

JOURNAL OF NEURAL TRANSMISSION. 2000; 107 (1): 31-40

7825

7825 Holzer M, Bruckner MK, Beck M, Bigl V, Arendt T

Modulation of APP processing and secretion by okadaic acid in primary guinea pig neurons

JOURNAL OF NEURAL TRANSMISSION. 2000; 107 (4): 451-461

7826

7826 Sjogren M, Minthon L, Davidsson P, Granerus AK, Clarberg A, et al.

CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging

JOURNAL OF NEURAL TRANSMISSION. 2000; 107 (5): 563-579

112

7827

7827 Wellington CL, Leavitt BR, Hayden MR

Huntington disease: new insights on the role of huntingtin cleavage

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2000; (58): 1-17

7828

7828 Shimizu N, Asakawa S, Minoshima S, Kitada T, Hattori N, et al.

PARKIN as a pathogenic gene for autosomal recessive juvenile parkinsonism

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2000; (58): 19-30

7829

7829 Gasser T

Autosomal-dominantly inherited forms of Parkinson's disease

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2000; (58): 31-40

7830

7830 McLean PJ, Ribich S, Hyman BT

Subcellular localization of alpha-synuclein in primary neuronal cultures: effect of missense mutations

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2000; (58): 53-63

Date / Author / Journal

LCS

GCS

LCR

7831

7831 Offen D, Elkon H, Melamed E

Apoptosis as a general cell death pathway in neurodegenerative diseases

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2000; (58): 153-166

7832

7832 Tsuji S

Dentatorubral-pallidoluysian atrophy (DRPLA)

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2000; (58): 167-180

102

7833

7833 Schmidt H, Fazekas F, Kostner GM, Schmidt R

Genetic aspects of microangiopathy-related cerebral damage

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2000; (59): 15-21

7834

7834 Jellinger KA, Stadelmann C

Mechanisms of cell death in neurodegenerative disorders

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2000; (59): 95-114

123

7835

7835 Albers DS, Beal MF

Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2000; (59): 133-154

119

185

7836

7836 Masliah E, Rockenstein E

Genetically altered transgenic models of Alzheimer's disease

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2000; (59): 175-183

7837

7837 Jellinger KA

Morphological substrates of mental dysfunction in Lewy body disease: an update

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2000; (59): 185-212

151

7838

7838 Iqbal K, Alonso AD, Gondal JA, Gong CX, Haque N, et al.

Mechanism of neurofibrillary degeneration and pharmacologic therapeutic approach

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2000; (59): 213-222

7839

7839 Wronski R, Kronawetter S, Hutter-Paier B, Crailsheim K, Windisch M

A brain derived peptide preparation reduces the translation dependent loss of a cytoskeletal protein in primary cultured chicken neurons

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2000; (59): 263-272

7840

7840 Morton AJ, Lagan MA, Skepper JN, Dunnett SB

Progressive formation of inclusions in the striatum and hippocampus of mice transgenic for the human Huntington's disease mutation

JOURNAL OF NEUROCYTOLOGY. 2000; 29 (9): 679-702

Date / Author / Journal

LCS

GCS

LCR

7841

7841 Chapman RS, Hesketh LJ

Behavioral phenotype of individuals with Down syndrome

MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS. 2000; 6 (2): 84-95

108

153

7842

7842 Kagoura M, Toyoda M, Matsui C, Morohashi M

Merkel cell carcinoma: an immunohistochemical and ultrastructural study

MERKEL CELLS, MERKEL CELL CARCINOMA AND NEUROBIOLOGY OF THE SKIN. 2000; 1187: 169-172

7843

7843 Lazarov NE

The mesencephalic trigeminal nucleus in the cat

MESENCEPHALIC TRIGEMINAL NUCLEUS IN THE CAT. 2000; 153: 1-+

431

7844

7844 Bornemann KD, Staufenbiel M

Transgenic mouse models of Alzheimer's disease

MOLECULAR AND CELLULAR GERONTOLOGY. 2000; 908: 260-266

7845

7845 Gomez-Tortosa E, Irizarry MC, Gomez-Isla T, Hyman BT

Clinical and neuropathological correlates of dementia with Lewy bodies

MOLECULAR BASIS OF DEMENTIA. 2000; 920: 9-15

7846

7846 Spillantini MG, Goedert M

The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy

MOLECULAR BASIS OF DEMENTIA. 2000; 920: 16-27

103

7847

7847 Polymeropoulos MH

Genetics of Parkinson's disease

MOLECULAR BASIS OF DEMENTIA. 2000; 920: 28-32

7848

7848 Kahle PJ, Neumann M, Ozmen L, Haass C

Physiology and pathophysiology of alpha-synuclein - Cell culture and transgenic animal models based on a Parkinson's disease-associated protein

MOLECULAR BASIS OF DEMENTIA. 2000; 920: 33-41

7849

7849 Conway KA, Lee SJ, Rochet JC, Ding TT, Harper JD, et al.

Accelerated oligomerization by Parkinson's disease linked alpha- synuclein mutants

MOLECULAR BASIS OF DEMENTIA. 2000; 920: 42-45

7850

7850 Neary D, Snowden JS, Mann DMA

Classification and description of frontotemporal dementias

MOLECULAR BASIS OF DEMENTIA. 2000; 920: 46-51

Date / Author / Journal

LCS

GCS

LCR

7851

7851 Ghetti B, Murrell JR, Zolo P, Spillantini MG, Goedert M

Progress in hereditary tauopathies: A mutation in the Tau gene (G389R) causes a Pick disease-like syndrome

MOLECULAR BASIS OF DEMENTIA. 2000; 920: 52-62

7852

7852 Hutton M

Molecular genetics of chromosome 17 tauopathies

MOLECULAR BASIS OF DEMENTIA. 2000; 920: 63-73

7853

7853 Goedert M, Ghetti B, Spillantini MG

Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) - Their relevance for understanding the neurogenerative process

MOLECULAR BASIS OF DEMENTIA. 2000; 920: 74-83

7854

7854 Finckh U, Muller-Thomsen T, Mann U, Eggers C, Marksteiner J, et al.

High frequency of mutations in four different disease genes in early- onset dementia

MOLECULAR BASIS OF DEMENTIA. 2000; 920: 100-106

7855

7855 Mailliot C, Bussiere T, Hamdane M, Sergeant N, Caillet ML, et al.

Pathological tau phenotypes - The weight of mutations, polymorphisms, and differential neuronal vulnerabilities

MOLECULAR BASIS OF DEMENTIA. 2000; 920: 107-114

7856

7856 Rosso SM, Kamphorst W, Ravid R, van Swieten JC

Coexistent tau and amyloid pathology in hereditary frontotemporal dementia with tau mutations

MOLECULAR BASIS OF DEMENTIA. 2000; 920: 115-119

7857

7857 Gotz J, Barmettler R, Ferrari A, Goedert M, Probst A, et al.

In vivo analysis of wild-type and FTDP-17 tau transgenic mice

MOLECULAR BASIS OF DEMENTIA. 2000; 920: 126-133

7858

7858 Price DL, Wong PC, Markowska AL, Lee MK, Thinakaren G, et al.

The value of transgenic models for the study of neurodegenerative diseases

MOLECULAR BASIS OF DEMENTIA. 2000; 920: 179-191

101

7859

7859 Barbas H

Complementary roles of prefrontal cortical regions in cognition, memory, and emotion in primates

NEOCORTICAL EPILEPSIES. 2000; 84: 87-110

216

7860

7860 Taylor DC

Cerebral lesions, psychoses, and epilepsy: Disease versus illness

NEOCORTICAL EPILEPSIES. 2000; 84: 463-477

Date / Author / Journal

LCS

GCS

LCR

7861

7861 Beattie MS, Li Q, Bresnahan JC

Cell death and plasticity after experimental spinal cord injury

NEURAL PLASTICITY AND REGENERATION. 2000; 128: 9-21

7862

7862 Bethea JR

Spinal cord injury-induced inflammation: a dual-edged sword

NEURAL PLASTICITY AND REGENERATION. 2000; 128: 33-42

7863

7863 Rao MS, Mayer-Proschel M

Precursor cells for transplantation

NEURAL PLASTICITY AND REGENERATION. 2000; 128: 273-292

167

7864

7864 Lee VMY, Hartley RS, Trojanowski JQ

Neurobiology of human neurons (NT2N) grafted into mouse spinal cord: implications for improving therapy of spinal cord injury

NEURAL PLASTICITY AND REGENERATION. 2000; 128: 299-307

7865

7865 Sinden JD, Stroemer P, Grigoryan G, Patel S, French SJ, et al.

Functional repair with neural stem cells

NEURAL TRANSPLANTATION IN NEURODEGENERATIVE DISEASE: CURRENT STATUS AND NEW DIRECTIONS. 2000; 231: 270-283

7866

7866 Kvetnoy IM, Hernandez-Yago J, Hernandez JM, Kvetnaia TV, Reiter RJ, et al.

Diffuse neuroendocrine system and mitochondrial diseases: molecular and cellular bases of pathogenesis, new approaches to diagnosis and therapy.

NEUROENDOCRINOLOGY LETTERS. 2000; 21 (2): 83-99

146

7867

7867 Kvetnoy IM, Hernandez-Yago J, Kvetnaia TV, Khavinson VK, Malinin VV, et al.

Tau-protein expression in human blood lymphocytes: a promising marker and suitable sample for life-time diagnosis of Alzheimer's disease

NEUROENDOCRINOLOGY LETTERS. 2000; 21 (4): 313-318

7868

7868 Chen JL, Li Y, Chopp M

Intracerebral transplantation of bone marrow with BDNF after MCAo in rat

NEUROPHARMACOLOGY. 2000; 39 (5): 711-716

7869

7869 Kimura T, Shono M, Yokota S, Igata-Yi R, Takamatsu J, et al.

Apolipoprotein E epsilon 3 allele is not a risk factor of schizophrenia: A study of 314 Japanese patients

NEUROPSYCHOBIOLOGY. 2000; 42 (2): 66-68

7870

7870 Puschban Z, Scherfler C, Granata R, Laboyrie P, Quinn NP, et al.

Autoradiographic study of striatal dopamine re-uptake sites and dopamine D-1 and D-2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts

NEUROSCIENCE. 2000; 95 (2): 377-388

Date / Author / Journal

7871

Cytotoxic lesion of the medial prefrontal cortex abolishes the partial reinforcement extinction effect, attenuates prepulse inhibition of the acoustic startle reflex and induces transient hyperlocomotion, while sparing spontaneous object recognition memory in the rat

NEUROSCIENCE. 2000; 95 (3): 675-689

7872

7872 Morrison B, Eberwine JH, Meaney DF, McIntosh TK

Traumatic injury induces differential expression of cell death genes in organotypic brain slice cultures determined by complementary DNA array hybridization

NEUROSCIENCE. 2000; 96 (1): 131-139

7873

7873 Kanda S, Bishop JF, Eglitis MA, Yang Y, Mouradian MM

Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation

NEUROSCIENCE. 2000; 97 (2): 279-284

118

123

7874

7874 Coughlan CM, McManus CM, Sharron M, Gao ZY, Murphy D, et al.

Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons

NEUROSCIENCE. 2000; 97 (3): 591-600

120

7875

7875 Ferrer I, Puig B, Blanco R, Marti E

Prion protein deposition and abnormal synaptic protein expression in the cerebellum in Creutzfeldt-Jakob disease

NEUROSCIENCE. 2000; 97 (4): 715-726

7876

7876 Sadahiro S, Yoshikawa H, Yagi N, Yamamoto Y, Yanagihara T, et al.NEUROSCIENCE. 2000; 98 (2): 361-367

7877

7877 Scherfler C, Puschban Z, Ghorayeb I, Goebel GP, Tison F, et al.

Complex motor disturbances in a sequential double lesion rat model of striatonigral degeneration (multiple system atrophy)

NEUROSCIENCE. 2000; 99 (1): 43-54

7878

7878 Shepherd CE, Bowes S, Parkinson D, Cambray-Deakin M, Pearson RCA

Expression of amyloid precursor protein in human astrocytes in vitro: Isoform-specific increases following heat shock

NEUROSCIENCE. 2000; 99 (2): 317-325

7879

7879 Newman MP, Feron F, Mackay-Sim A

Growth factor regulation of neurogenesis in adult olfactory epithelium.

NEUROSCIENCE. 2000; 99 (2): 343-350

7880

7880 Blaha GR, Raghupathi R, Saatman KE, Mcintosh TK

Brain-derived neurotrophic factor administration after traumatic brain injury in the rat does not protect against behavioral or histological deficits

NEUROSCIENCE. 2000; 99 (3): 483-493

Date / Author / Journal

LCS

GCS

LCR

7881

7881 Kawamoto Y, Nakamura S, Matsuo A, Akiguchi I, Shibasaki H

Immunohistochemical localization of glial cell line-derived neurotrophic factor in the human central nervous system

NEUROSCIENCE. 2000; 100 (4): 701-712

7882

7882 Harkany T, Dijkstra IM, Oosterink BJ, Horvath KM, Abraham I, et al.

Increased amyloid precursor protein expression and serotonergic sprouting following excitotoxic lesion of the rat magnocellular nucleus basalis: Neuroprotection by Ca2+ antagonist nimodipine

NEUROSCIENCE. 2000; 101 (1): 101-114

7883

7883 Burke WJ, Li SW, Schmitt CA, Zahm DS, Chung HD, et al.

Catecholamine-derived aldehyde neurotoxins

NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS. 2000; : 167-180

7884

7884 Dryhurst G, Shen XM, Li H, Yang ZL, Han JL, et al.

Potential roles of accelerated dopamine oxidation, altered glutathione metabolism, 5-S-cysteinyl-dopamine and its oxidative metabolites in the pathogenesis of Parkinson's disease

NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS. 2000; : 181-209

164

7885

7885 Feany MB

Simple genetic models of human neurologic disease

NEW CONCEPTS IN THE IMMUNOPATHOGENESIS OF CNS INFECTIONS. 2000; : 337-360

124

7886

7886 Braak H, Del Tredici K, Bohl J, Bratzke H, Braak E

Pathological changes in the parahippocampal region in select non- Alzheimer's dementias

PARAHIPPOCAMPAL REGION. 2000; 911: 221-239

7887

7887 Van Hoesen GW, Augustinack JC, Dierking J, Redman SJ, Thangavel R

The parahippocampal gyrus in Alzheimer's disease - Clinical and preclinical neuroanatomical correlates

PARAHIPPOCAMPAL REGION. 2000; 911: 254-274

7888

7888 Arnold SE

Cellular and molecular neuropathology of the parahippocampal region in schizophrenia

PARAHIPPOCAMPAL REGION. 2000; 911: 275-292

111

7889

7889 Benes FM, Berretta S

Amygdalo-entorhinal inputs to the hippocampal formation in relation to schizophrenia

PARAHIPPOCAMPAL REGION. 2000; 911: 293-304

7890

7890 Pow CS, Whitehead JS, Moss MS

Immunohistochemistry: Methods and troubleshooting

PATHOLOGY OF GENETICALLY ENGINEERED MICE. 2000; : 23-32

Date / Author / Journal

LCS

GCS

LCR

7891

7891 Lomnitski L, Nyska A, Michaelson DM

Transgenic and knockout mice with neuropathological disorders

PATHOLOGY OF GENETICALLY ENGINEERED MICE. 2000; : 253-268

7892

7892 Adesina AM, Dunn ST, Moore WE, Nalbantoglu J

Expression of p27kip1 and p53 in medulloblastoma: Relationship with cell proliferation and survival

PATHOLOGY RESEARCH AND PRACTICE. 2000; 196 (4): 243-250

7893

7893 Bartold PM, Walsh LJ, Narayanan S

Molecular and cell biology of the gingiva

PERIODONTOLOGY 2000. 2000; 24: 28-55

242

7894

7894 Lin B, Ginsberg MD

The roles of beta-amyloid precursor protein and amyloid beta peptide in ischemic brain injury

PHARMACOLOGY OF CEREBRAL ISCHEMIA 2000. 2000; : 37-52

109

7895

7895 Schallert T, Bland ST, Fleming SM

Functional recovery after brain injury: role of neurotrophic factors and behavior-driven structural events

PHARMACOLOGY OF CEREBRAL ISCHEMIA 2000. 2000; : 329-344

164

7896

7896 Loddick SA

Inflammatory and anti-inflammatory cytokines and neuronal cell death

PHARMACOLOGY OF CEREBRAL ISCHEMIA 2000. 2000; : 417-424

7897

7897 Chopp M, Li Y, Chen J

Treatment of neural injury with bone marrow

PHARMACOLOGY OF CEREBRAL ISCHEMIA 2000. 2000; : 483-490

7898

7898 Chen SG, Zou W, Parchi P, Gambetti P

PrPSc typing by N-terminal sequencing and mass spectrometry

PRION DISEASES. 2000; : 209-216

7899

7899 Safar J, Cohen FE, Prusiner SB

Quantitative traits of prion strains are enciphered in the conformation of the prion protein

PRION DISEASES. 2000; : 227-235

7900

7900 Poljak A, Pamphlett R, Gurney ME, Duncan MW

Measurement of o- and m-tyrosine as markers of oxidative damage in motor neuron disease

REDOX REPORT. 2000; 5 (2-3): 137-140

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records